[Anastrozolo: intracellular anti-aromatase activity and pharmacologic interactions. Satellite Symposium AIOM 1999 - Roma].
Longo
F
F
Mansueto
G
G
D000077384:Anastrozole; D000818:Animals; D018931:Antineoplastic Agents, Hormonal / Q000494:pharmacology* / Q000627:therapeutic use; D047072:Aromatase Inhibitors; D017024:Chemotherapy, Adjuvant; D004347:Drug Interactions; D004791:Enzyme Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D004958:Estradiol / Q000031:analogs & derivatives* / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D020847:Estrogen Receptor Modulators / Q000494:pharmacology* / Q000627:therapeutic use; D004967:Estrogens / Q000097:blood; D005260:Female; D000077267:Fulvestrant; D006801:Humans; D009570:Nitriles / Q000494:pharmacology* / Q000627:therapeutic use; D010053:Ovary / Q000187:drug effects; D013629:Tamoxifen / Q000494:pharmacology; D014230:Triazoles / Q000494:pharmacology* / Q000627:therapeutic use
D018931:Antineoplastic Agents, Hormonal; D047072:Aromatase Inhibitors; D004791:Enzyme Inhibitors; D020847:Estrogen Receptor Modulators; D004967:Estrogens; D009570:Nitriles; D014230:Triazoles; D013629:Tamoxifen; D000077267:Fulvestrant; D000077384:Anastrozole; D004958:Estradiol